欢迎访问《岭南现代临床外科》官方网站,今天是

岭南现代临床外科 ›› 2018, Vol. 18 ›› Issue (04): 414-417.DOI: 10.3969/j.issn.1009-976X.2018.04.011

• 论著与临床研究 • 上一篇    下一篇

GN之后序贯口服N治疗晚期乳腺癌的临床观察与分析

张凯, 罗智辉, 黄湛, 宫绪萌, 陈伟玲   

  1. 粤北人民医院
  • 通讯作者: 张凯

Clinical Comparison of Gemcitabine Combined Vinorelbine×8 Regimen Versus Gemcitabine Combined Vinorelbine×4 follow oral N ×4 Regimen as Chemotherapy for Metastatic Breast Cancer

ZHANG Kai,LUO Zhihui,HUANG Zhan,GONG Xumeng,CHEN Weiling   

  1. Department of Breast Oncology,Yuebei People’s Hospital,Shaoguan,Guangdong 512025,China
  • Online:2018-08-20 Published:2018-08-20

摘要: [摘要] 目的 比较 GN(吉西他滨/长春瑞滨)4 疗程后序贯 GN×4(GN×8 组)或序贯口服 N×4 方案(GN×4?N 组)治疗对晚期乳腺癌(MBC)的疗效及不良反应。方法 选取2014 年1 月至2015 年12 月确诊的晚期乳腺癌患者 61 人,采用 GN×4 疗程后序贯 GN×4 或序贯口服N×4 方案化疗,比较患者的总有效率(ORR)及 1 年生存率。结果 GN×8 组 ORR 为 35.5%(11/31),其中 CR 6.5%(2/31),PR 29%(9/31);GN×4?N 组 ORR 为 33.3%(10/30),其中 CR 6.7%(2/30),PR 26.7%(8/30),两组 ORR 差异无统计学意义(P=0.925),GN×8 组 1 年生存率为 67.7%;GN×4?N 组 1 年生存率为65.5%,两组1 年生存率差异无统计学意义(P=0.576)。两组均无化疗相关死亡病例,主要不良反应为骨髓抑制及胃肠道反应。结论 GN4 疗程后序贯GN×4 或序贯口服N×4 方案对于MBC 均有较好的有效率,不良反应均可耐受。但从药物经济学及患者的生活质量上讲,GN×4?N 更符合晚期治疗患者“低毒高效、服用方便”的原则。

关键词: 口服长春瑞滨, 吉西他滨, 化疗, 乳腺癌

Abstract: ABSTRACT BACKGROUND&OBJECTIVE:. To compare the efficacy and toxicities of gemcitabine combined vinorelbine ( GN) ×8 regimen and gemcitabine combined vinorelbine ( GN) ×4 follow oral N ×4 regimen as chemotherapy for anthracycline- and taxane- resistant metastatic breast cancer(MBC) Patients and Methods:. 61 patients were treated by GN or GN×4— N regimen. Overall response rate( ORR) and 1- year survival of two groups were assessed after treatment RESULTS:CR was 6. 5% ( 2 /31) and PR was 29.0% (9 /31) in GN group. 2 patients ( 6.9% ) had a complete response( CR) and 8 patients ( 27.6% ) had a partial response( PR) in GN×4—N group. No statistically significant difference was observed in terms of ORR( 35.5% vs. 33.3%. , P =0.925) , or 1- year survival rate ( 67.7% vs. 65.5%, P =0.576) of the two groups. No patients died in correlated with the two regimens. Myelosuppression and gastrointestinaltract reaction were the most common toxicities. CONCLUSIONS:. GN and GN×4—N regimens are both well effective for patients with anthracycline- and taxane- resistant MBC. Drug- related toxicities are tolerable. Two regimens can be considered as salvage regimens for those patients.